| Motesanib studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT01349088Phase 1/Phase 2 · withdrawn Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer · 21 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427349Phase 2 · completed AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors · 21 trials list this drug (0 active) | — | — | Digestive System Neuroendocrine Tumor G1,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574951Phase 2 · terminated AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · 21 trials list this drug (0 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369070Phase 2 · terminated A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC · 21 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861419Phase 1 · completed To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. · 21 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094835Phase 1/Phase 2 · completed Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) · 21 trials list this drug (0 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02629848Phase 3 · terminated Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer · 21 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356681Phase 2 · terminated A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer · 21 trials list this drug (0 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00360867Phase 2 · terminated An Open Label Treatment Extension Study of AMG 706 · 21 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00460317Phase 3 · terminated MONET1-MOtesanib NSCLC Efficacy and Tolerability Study · 21 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101907Phase 1 · terminated Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer · 21 trials list this drug (0 active) | — | — | Malignant Esophageal Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254267Phase 2 · completed Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors · 21 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121628Phase 2 · completed A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer · 21 trials list this drug (0 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324597Phase 1 · unknown AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma · 21 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Lymphoma,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322400Phase 1 · completed Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer · 21 trials list this drug (0 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093873Phase 1 · completed Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors · 21 trials list this drug (0 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089960Phase 2 · completed Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) · 21 trials list this drug (0 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101894Phase 1 · completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer · 21 trials list this drug (0 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386866Phase 1 · completed Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors · 21 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00448786Phase 1 · completed Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors · 21 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235416Phase 1 · completed A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors · 21 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |